General Information
BounceWatch is an independent company data service, not affiliated with ImmunoACT. To contact ImmunoACT, visit ImmunoACT.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ImmunoACT compare?
A PDF of ImmunoACT and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ImmunoACT soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is ImmunoACT on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
India Market
Biotechnology
About ImmunoACT
Business keywords: Cell therapy, Gene therapy, IIT-Bombay, Startup, Translational research, Viral vector process development, Autologous CAR-T cell therapies, Blood cancers, Healthcare innovation, Drug development, Medical advancements
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Secondary Market | INR40.00M | - |
|
31 May 2023 |
| Corporate Round | INR800.00M | 1 |
Laurus Labs
|
31 May 2023 |
| Corporate Round | INR557.50M | 1 |
Laurus Labs
|
19 Nov 2021 |
ImmunoACT Alternatives & Competitors
View All AlternativesA unique full-service CDMO, setting new standards in Cell & Gene Therapy
Your Advanced Cell & Gene Therapy CDMO Partner
Nanomechanical Gene Delivery to Transform the Engineering of Cell Based Therapies
FAQ About ImmunoACT
Source: BounceWatch company record for ImmunoACT, https://bouncewatch.com/company/immunoact, updated 28 October 2024. When citing, please name BounceWatch and link this page.